Gilead Sciences, Inc. (GILD)

64.05
0.99 1.50
NASDAQ
Prev Close 65.04
Open 64.95
Day Low/High 64.05 / 65.17
52 Wk Low/High 60.89 / 85.97
Volume 14.26M
Exchange NASDAQ
Shares Outstanding 1253.72B
Market Cap 81.54B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

The Best Way to Navigate This Market

The Best Way to Navigate This Market

As is so often the case, the bears are unable to close the deal when it looks like they have an edge.

Jim Cramer: Is This Market Undervalued?

Jim Cramer: Is This Market Undervalued?

Stocks are reasonable. Or even cheap. There will be more sell-offs ahead but remember this day and do not get too negative.

How About That Merck and Seattle Genetics Deal?

How About That Merck and Seattle Genetics Deal?

I am long Merck, not Seattle Genetics, though the one to own now is obviously SGEN.

Spate of Deal News Juices Start of This Week's Trading

Spate of Deal News Juices Start of This Week's Trading

We've become accustomed lately to gap-up opens on Mondays, but some fresh acquisition agreements are helping drive this Monday's action.

Jim Cramer: Sorry to Burst Your Bubble, but the Fed Bubble Talk Isn't True

Jim Cramer: Sorry to Burst Your Bubble, but the Fed Bubble Talk Isn't True

The Fed's money pumping has elevated new tech, but Jay Powell and the government haven't done any favors for many other stocks.

2 Candidates to Consider as Biotech Buyout Activity Picks Up

2 Candidates to Consider as Biotech Buyout Activity Picks Up

A handful of deals have been announced this week alone and they give rise to expectations of more acquisitions to come.

A Healthy Dose of Vaccine and Pharmaceutical Plays

A Healthy Dose of Vaccine and Pharmaceutical Plays

6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.

Here's How I'm Trading XBiotech

Here's How I'm Trading XBiotech

Do these shares get back to the 2020 highs that were reached back in January?

Bearish Bets: 2 Well-Known Stocks You Should Consider Shorting This Week

Bearish Bets: 2 Well-Known Stocks You Should Consider Shorting This Week

These familiar names are displaying both technical and quantitative deterioration.

Big Tech's Big Night, Eyeing Amazon, My Kodak Moment, Powell's Blunt Assessment

Big Tech's Big Night, Eyeing Amazon, My Kodak Moment, Powell's Blunt Assessment

The Fed has done a lot, and is willing to do even more, but for now, is watching Congress. The fiscal side is where the next shoe falls.

Gilead Sciences Could Dip a Little in Reaction to Earnings

Gilead Sciences Could Dip a Little in Reaction to Earnings

The charts are looking soft right now.

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Our fate is in the hands of a few dozen companies with a dizzying array of clinical trials, and whoever gets there first is gonna make a fortune.

Charting the Stocks of 3 Covid Treatment Companies

Charting the Stocks of 3 Covid Treatment Companies

Let's take a close look at Gilead Sciences, Regeneron and Eli Lilly.

Gilead Sciences Is Set to Break Out: How to Play It

Gilead Sciences Is Set to Break Out: How to Play It

The stock is trading above the 50-day and the 200-day moving averages.

Count Me a Covid-19 Skeptic, Including When It Comes to a Vaccine

Count Me a Covid-19 Skeptic, Including When It Comes to a Vaccine

The extent of the measures taken to combat the virus seem to be an overreaction, and no one should count on a vaccine being a magic bullet.

Regeneron, PayPal, Facebook Push Up Real Money Post Industrial Average

Regeneron, PayPal, Facebook Push Up Real Money Post Industrial Average

The RMPIA rose 3.2% for May and 3.3% for the first five months of 2020.

Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine

Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine

When I first started buying ARCT shares I didn't conceive of a valuation of $1 billion, but I also didn't conceive of the global impact of a pandemic.

Merck Is All In With a Threefold Approach to Covid-19

Merck Is All In With a Threefold Approach to Covid-19

I've been long Merck for a long time, since way before this pandemic became part of our lives.

Gilead Raised to Hold at SunTrust

Mr. Market Has Been Dead Right on General Electric

Mr. Market Has Been Dead Right on General Electric

GE's problem can be summarized in one sentence: The company is burning cash.

Jim Cramer: The Hope Is Real

Jim Cramer: The Hope Is Real

I get this rally -- it's based on more than a breaking branch this time, but there are still many uncertainties.

Want to Know Why I'm Not Selling Moderna?

Want to Know Why I'm Not Selling Moderna?

I'm staying long this name, and I'm staying long PFE and JNJ, and I'm staying long GILD and ABT. You know why? Because I'm optimistic.

Covering All Bases With Pfizer as It Aggressively Pursues a Covid-19 Vaccine

Covering All Bases With Pfizer as It Aggressively Pursues a Covid-19 Vaccine

PFE is collaborating with German drugmaker BioNTech in the effort to find a well tolerated, effective vaccine.

Skating on Thin Ice, Apple and Amazon Earnings, the Price of Uncertainty

Skating on Thin Ice, Apple and Amazon Earnings, the Price of Uncertainty

This contraction has been dramatic and unpredictable -- and best outcomes cannot be driven solely through economic creativity.

Boeing Has My Eye

Boeing Has My Eye

This is a lower probability trade, but with the coiled price action around BA, it wouldn't take much to spring this one to life.

As Emotions Cool, Here's My Market View

As Emotions Cool, Here's My Market View

My strategy here is to focus on shorter-term trades.

A Time to Plant And a Time to Pluck Up That Which Is Planted

* Mission accomplished? Sell in May and go away!  * In scope and duration, stocks have rallied in a manner rarely seen in history * Month-to-date April has been the best month for equities since 1974 * The S&P Index has climbed by +31.4% since the M...

Has the Fed Eliminated the Risk of a Meaningful Pullback?

Has the Fed Eliminated the Risk of a Meaningful Pullback?

While the power of the Fed is unquestionable, there will be issues that liquidity simply can't fix.